SCHEMBL5111285

SCHEMBL5111285

NC(=O)c1ccc(-n2ncccc2=O)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
DGAT1 O75907 1/20 0.43
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
F10 P00742 1/20 0.41
RIPK2 O43353 1/20 0.38
P2RX7 Q99572 1/20 0.37
PDE4B Q07343 1/20 0.36
ACVR1 Q04771 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CAPN1 P07384 1/20 0.35
TYK2 P29597 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346868 0.89 CA12 (0.47) CA12CA1CA2CA9LMNA
SCHEMBL6525684 0.83 CA12 (0.41) CA12CA1CA2CA9LMNA
SCHEMBL3343670 0.81 CA1 (0.47) CA12CA1CA2CA9LMNA
SCHEMBL3834632 0.80 CA1 (0.51) CA12CA1CA2CA9LMNA
SCHEMBL6240657 0.79 DGAT1 (0.44) DGAT1LMNARAB9ASMN1; SMN2ACVR1
SCHEMBL31038311 0.77 CA12 (0.44) CA12CA1CA2CA9LMNA
SCHEMBL6243545 0.77 KAT6A (0.48) DGAT1LMNAKDM4ECAPN1
SCHEMBL3346872 0.77 CA1 (0.51) CA12CA1CA2CA9LMNA
SCHEMBL14955412 0.76 CA12 (0.49) CA12CA1CA2CA9F10
SCHEMBL1030894 0.75 F10 (0.47) DGAT1F10PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407972-B2 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade PFIZER INC. (US) 2008-08-05 US disclosed
US-20060264626-A1 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE WARNER-LAMBERT COMPANY LLC 2006-11-23 US disclosed
US-20050267118-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade WARNER-LAMBERT COMPANY LLC 2005-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050267118-A1 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade F12, TFPI, F11 CA12 646/4885CA1 540/4885CA2 1283/4885
US-20060264626-A1 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE F11, F2, TFPI CA12 1116/4885CA1 945/4885CA2 2885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.